These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 16220017

  • 1. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
    Cojocel C, Al-Maghrebi M, Thomson MS, Rawoot P, Raghupathy R.
    Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
    [Abstract] [Full Text] [Related]

  • 2. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
    Lai PB, Zhang L, Yang LY.
    Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
    [Abstract] [Full Text] [Related]

  • 3. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J, Jia R, Bao Y.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
    Roy S, Dontamalla SK, Mondru AK, Sannigrahi S, Veerareddy PR.
    Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
    [Abstract] [Full Text] [Related]

  • 6. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Auton Neurosci; 2003 Mar 28; 104(2):88-94. PubMed ID: 12648610
    [Abstract] [Full Text] [Related]

  • 7. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y, Gu Y, Ma J, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):239-43. PubMed ID: 11953170
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB.
    Am J Physiol Renal Physiol; 2009 Sep 25; 297(3):F729-39. PubMed ID: 19553350
    [Abstract] [Full Text] [Related]

  • 9. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway.
    Li C, Cai F, Yang Y, Zhao X, Wang C, Li J, Jia Y, Tang J, Liu Q.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):382-9. PubMed ID: 20854812
    [Abstract] [Full Text] [Related]

  • 10. 17β-Estradiol and vitamin E modulates oxidative stress-induced kidney toxicity in diabetic ovariectomized rat.
    Ulas M, Cay M.
    Biol Trace Elem Res; 2011 Dec 15; 144(1-3):821-31. PubMed ID: 21484408
    [Abstract] [Full Text] [Related]

  • 11. Effects of stobadine and vitamin E in diabetes-induced retinal abnormalities: involvement of oxidative stress.
    Yülek F, Or M, Ozoğul C, Isik AC, Ari N, Stefek M, Bauer V, Karasu C.
    Arch Med Res; 2007 Jul 15; 38(5):503-11. PubMed ID: 17560455
    [Abstract] [Full Text] [Related]

  • 12. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats.
    Reddi AS, Bollineni JS.
    Kidney Int; 2001 Apr 15; 59(4):1342-53. PubMed ID: 11260395
    [Abstract] [Full Text] [Related]

  • 13. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 15; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 14. Puberty permits increased expression of renal transforming growth factor-beta1 in experimental diabetes.
    Lane PH, Snelling DM, Hollman A, Langer WJ.
    Pediatr Nephrol; 2001 Dec 15; 16(12):1033-9. PubMed ID: 11793095
    [Abstract] [Full Text] [Related]

  • 15. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
    Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z, Ni J, Yu C, Yao T, Huang Y, Wang R, Lu L.
    Nephrol Dial Transplant; 2011 Jul 15; 26(7):2119-26. PubMed ID: 21208996
    [Abstract] [Full Text] [Related]

  • 16. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Jul 15; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 17. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM, del Re E, Brown D, Lin HY.
    Diabetes; 2007 Feb 15; 56(2):380-8. PubMed ID: 17259382
    [Abstract] [Full Text] [Related]

  • 18. Valsartan attenuated oxidative stress, decreased MCP-1 and TGF-β1 expression in glomerular mesangial and epithelial cells induced by high-glucose levels.
    Jiao B, Wang YS, Cheng YN, Gao JJ, Zhang QZ.
    Biosci Trends; 2011 Aug 15; 5(4):173-81. PubMed ID: 21914953
    [Abstract] [Full Text] [Related]

  • 19. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
    D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H.
    Horm Metab Res; 2001 Nov 15; 33(11):664-9. PubMed ID: 11733869
    [Abstract] [Full Text] [Related]

  • 20. Protease administration decreases enhanced transforming growth factor-beta 1 content in isolated glomeruli of diabetic rats.
    Paczek L, Gaciong Z, Bartlomiejczyk I, Sebekova K, Birkenmeier G, Heidland A.
    Drugs Exp Clin Res; 2001 Nov 15; 27(4):141-9. PubMed ID: 11822224
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.